SEARCH

SEARCH BY CITATION

References

  • ANDREIS, P.G., NERI, G., BELLONI, A.S., MAZZOCCHI, G., KASPRZAK, A. & NUSSDORFER, G.G. (1991). Interleukin-1 beta enhances corticosterone secretion by acting directly on the rat adrenal gland. Endocrinology, 129, 5357.
  • AUDHYA, T., RAJEEV, J. & HOLLANDER, C. (1991). Receptor-mediated immunomodulation by corticotropin-releasing factor. Cell. Immunol., 134, 7780.
  • BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248254.
  • BUSSE, R. & MULSCH, A. (1990). Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett., 275, 8790.
  • BUSSOLINO, F., DE ROSSI, M., SICA, A., COLOTTA, F., WANG, J.M., BOCCHIETTO, E., PADURA, I.M., BOSIA, A., DEJANA, E. & MANTOVANI, A. (1991). Murine endothelioma cell lines transformed by polyoma middle T oncogene as target for and producer of cytokines. J. Immunol., 147, 21222129.
  • CHANG, C.P., PEARSE, R.V., O'CONNELL, S. & ROSENFELD, M.G. (1993). Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron, 11, 11871195.
  • CHEN, R., LEWIS, K.A., PERRIN, M.H. & VALE, W.W. (1993). Expression of a human corticotropin-releasing factor receptor. Proc. Natl. Acad. Sci. U.S.A., 90, 89678971.
  • CHOMCZYNSKI, P. & SACCHI, N. (1987). Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156159.
  • CLIFTON, V.L., READ, M.A., LEITCH, I.M., GILES, W.B., BOURA, A.L.A., ROBINSON, P.J. & SMITH, R. (1995). Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxyde-cyclic guanosine 3′,5′-monophosphate-mediated pathway. J. Clin. Endocrinol. Metab., 80, 28882893.
  • CORREA, S.G., RIERA, C.M., SPIESS, J. & BIANCO, J.D. (1997). Modulation of the inflammatory response by corticotropin releasing factor. Eur. J. Pharmacol., 319, 8591.
  • CROFFORD, L.J., SANO, H., KARALIS, K., FRIEDMAN, T.C., EPPS, H.R., REMMERS, E.F., MATHERN, P., CHROUSOS, G.P. & WILDER, R.L. (1993). Corticotropin-releasing hormone in synovial fluids of patients with rheumatoid arthritis and osteoarthritis. J. Immunol., 151, 15871593.
  • DUFAU, M.L., TINAJERO, J.C. & FABBRI, A. (1993). Corticotropin-releasing factor: an antireproductive hormone of the testis. FASEB J., 7, 299307.
  • FLEISHER-BERKOVICH, S. & DANON, A. (1995). Effect of corticotropin-releasing factor on prostaglandin synthesis in endothelial cells and fibroblasts. Endocrinology, 136, 40684072.
  • GHIGO, D., ARESE, M., TODDE, R., VECCHI, A., SILVAGNO, F., COSTAMAGNA, C., DONG, Q.G., ALESSIO, M., HELLER, R., SOLDI, R., TRUCCO, F., GARBARINO, G., PESCARMONA, G., MANTOVANI, A., BUSSOLINO, F. & BOSIA, A. (1995). Middle T antigen-transformed endothelial cells exhibit an increased activity of nitric oxide synthase. J. Exp. Med., 181, 919.
  • GREEN, L.C., WAGNER, D.A., GLOGOWSKI, J., SKIPPER, P.L., WISHNOK, J.S. & TANNENBAUM, S.R. (1982). Analysis of nitrate, nitrite, and [16N]nitrate in biological fluids. Anal. Biochem., 126, 131138.
  • GOLD, P.W., LORIAUX, D.L., ROY, A., KLING, M.A., CALABRESE, J.R., KELLNER, C.H., NIEMAN, L.K., POST, R.M., PICKAR, D., GALLUCCI, W.T., AVGERINOS, P., PAUL, S., OLDFIELD, E.H., CUTLER JR., J.B. & CHROUSOS, G.P. (1986). Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. N. Engl. J. Med., 314, 13291336.
  • IAVICOLI, S., LOPEZ-PEREZ, E., BUEHRING, G.C., THOMAS, H.A., WEI, E.T. & KISHIMOTO, T. (1998). Bipolar-shape response of human neutrophils to corticotropin-releasing factor. Eur. J. Pharmacol., 349, 301306.
  • INTRONA, M., COLOTTA, F., SOZZANI, S., DEJANA, E. & MANTOVANI, A. (1994). Pro- and anti-inflammatory cytokines: interactions with vascular endothelium. Clin. Exp. Rheumatol., 12, S19S23.
  • KAPCALA, L.P. & DE SOUZA, E.B. (1988). Characterization of corticotropin-releasing factor receptors in dissociated brain cell cultures. Brain Res., 456, 159167.
  • KARALIS, K., SANO, H., REDWINE, J., LISTWAK, S., WILDER, R.L. & CHROUSOS, G.P. (1991). Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science, 254, 421423.
  • KARTERIS, E., GRAMMATOPOULOS, D., DAI, Y., OLAH, K.B., GHOBARA, T.B., EASTON, A. & HILLHOUSE, E.W. (1998). The human placenta and fetal membranes express the corticotropin-releasing hormone receptor 1 alpha (CRH-R1 alpha) and the CRH-C variant receptor. J. Clin. Endocrinol. Metab., 83, 13761379.
  • LAMAS, S., MARSDEN, P.A., LI, G.K., TEMPST, P. & MICHEL, T. (1992). Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc. Natl. Acad. Sci. U.S.A., 89, 63486352.
  • MCLOON, L.K. & WIRTSCHAFTER, J. (1997). Local injection of Corticotropin-releasing factor reduce doxorubicin-induced acute inflammation in the eyelid. Invest. Ophtalm. Vis. Sci., 38, 834841.
  • MOUSA, S.A., SCHAFER, M., MITCHELL, W.M., HASSAN, A.H.S. & STEIN, C. (1996). Local up-regulation of corticotropin-releasing hormone and interleukin-1 receptor in rat with painful hindlimb inflammation. Eur. J. Pharmacol., 311, 221228.
  • MUNCK, A., GUYRE, P.M. & HOLBROOK, N.J. (1984). Physiological function of glucocorticoids in stress and their relation to pharmacological action. Endocrine Rev., 5, 2560.
  • PERRIN, M.H., DONALDSON, C.J., CHEN, R., LEWIS, K.A. & VALE, W.W. (1993). Cloning and functional expression of a rat brain corticotropin-releasing factor (CRF) receptor. Endocrinology, 133, 30583061.
  • PERRIN, M., DONALDSON, C., CHEN, R., BLOUNT, A., BERGGREN, T., BILEZIKJIAN, L., SAWCHENKO, P. & VALE, W. (1995). Identification of a second corticotropin-releasing factor receptor gene and caracterization of a cDNA expressed in heart. Proc. Natl. Acad. Sci. U.S.A., 92, 29692973.
  • PETRAGLIA, F., SAWCHENKO, P.E., RIVIER, J. & VALE, W. (1987). Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature, 328, 717719.
  • RADULOVIC, J., RUHMANN, A., LIEPOLD, T. & SPIESS, J. (1999). Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J. Neurosci., 19, 56165625.
  • RAO, K.M. (2000). Molecular mechanisms regulating iNOS expression in various cell types. J. Toxicol. Environ. Health B. Crit. Rev., 3, 2758.
  • RUHMANN, A., BONK, I., LIN, C.R., ROSENFELD, M.G. & SPIESS, J. (1998). Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRHR): development of CRFR2β selective antisauvagine-30. Proc. Natl. Acad. Sci. U.S.A., 95, 1526415269.
  • SAKAI, Y., HORIBA, N., SAKAI, K., TOZAWA, F., KUWAYAMA, A., DEMURA, H. & SUDA, T. (1997). Corticotropin-releasing factor up-regulates its own receptor gene expression in corticotropic adenoma cells in vitro. J. Clin. Endocrinol. Metab., 82, 12291234.
  • SAWCHENKO, P.E. & SWANSON, L.W. (1985). Localization, co-localization and plasticity of corticotropin-releasing factor immunoreactivity in rat brain. Fed. Proc., 44, 232237.
  • SCHULZ, D.W., MANSBACH, R.S., SPROUSE, J., BRASELTON, J.P., COLLINS, J., CORMAN, M., DUNAISKIS, A., FARACI, S., SCHMIDT, A.W., SEEGER, T., SEYMOUR, P., TINGLEY, F.D.III, , WINSTON, E.N., CHEN, Y.L. & HEYM, J. (1996). CP-154,526: a potent and selective nonpeptide antagonist of corticotropin-releasing factor receptor. Proc. Natl. Acad. Sci. U.S.A., 93, 1047710482.
  • SIMONCINI, T., APA, R., REIS, F.M., MICELI, F., STOMATI, M., DRIUL, L., LANZONE, A., GENAZZANI, A.R. & PETRAGLIA, F. (1999). Human umbilical vein endothelial cells: a new source and potential target for corticotropin-releasing factor. J. Clin. Endocrinol. Metab., 84, 28022806.
  • SINGH, V.K. & FUDENBERG, H.H. (1988). Binding of [125I]corticotropin-releasing factor to blood immunocytes and its reduction in Alzheimer's disease. Immunol. Lett., 18, 59.
  • STEPHANOU, A., JESSOP, D.S., KNIGHT, R.A. & LIGHTMAN, S.L. (1990). Corticotropin-releasing factor like immunoreactivity and mRNA in human leukocytes. Brain Behav. Immun., 4, 6771.
  • THIEMMERMANN, C. (1994). The role of arginine: nitric oxide pathway in circulatory shock. Adv. Pharmacol., 28, 4975.
  • WEBSTER, E.L. & DESOUSA, E.B. (1983). CRH receptors in mouse spleen: identification, localization and regulation by divalent cations and guanine nucleotides. Endocrinology, 122, 609617.
  • WEBSTER, E.L., TRACEY, D.E., JUTILA, M.A., WOLFE JR., S.A. & DE SOUZA, E.B. (1990). Corticotropin releasing factor receptors in mouse spleen: identification of receptor-bearing cells as resident macrophages. Endocrinology, 127, 440445.
  • XIN, Q.W., CHO, H.J., CALAYCAY, J., MUMFORD, R.A., SWIDEREK, K.M., LEE, T.D., DING, A., TROSO, T. & NATHAN, C. (1992). Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science, 256, 225227.
  • ZICHE, M., MORBIDELLI, L., MASINI, E., AMERINI, S., GRANGER, H.J., MAGGI, C.A., GEPPETTI, P. & LEDDA, F. (1994). Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest., 94, 20362044.